SALIX MISSES ESTIMATES; PHARMACEUTICAL FIRM'S STOCK PUMMELED

Shares in pharmaceutical firm Salix plummeted nearly 11 percent on Thursday after the company missed Wall Street analysts' expectations on quarterly earnings. Salix reported a net income of $3.7 million, or 8 cents a share. Analysts had forecast a 12-cent per share profit. Local Tech Wire (http://www.localtechwire.com/article.cfm?u=13935)